Amy E. McKee, Director at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 11,180 shares at $8.97 ($100K) on 2026-05-18, disclosed to the SEC on 2026-05-19.
Open-market sale of $100k BCRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.